North America Medical Device Plastics Market

The North America medical device plastics market is projected to grow from USD 4.07 billion in 2025 to USD 5.95 billion by 2030, at a CAGR of 7.9% during the forecast period. The North American market for medical device plastics continues to grow as both the healthcare and medical device industries require more plastic products. The demand for high-performance plastic components is rising as surgical procedures increase, particularly for minimally invasive and outpatient treatments. The market needs lightweight, biocompatible, and durable plastics because wearable medical devices and drug delivery systems continue to expand. The aging population and the increasing number of patients with chronic diseases require more advanced medical devices and single-use products.

SMC Limited (US), Phillips Medisize (US), Freudenberg Medical (US), Jabil (US), Spectrum Plastics Group (US), Proto Labs (US), and Technimark LLC (US) are some key players in the market. These companies are strong in their home regions and are exploring geographic diversification options to grow their businesses. They focus on increasing their market shares through product launches and other expansions.

To know about the assumptions considered for the study download the pdf brochure

SMC Ltd (US) offers a comprehensive manufacturing solution that provides customers with design, prototyping, and manufacturing services to help North American medical device companies bring their products to market faster. The company specializes in thermoplastic and silicone injection molding, along with precision tooling and automation, and develops complex devices, including drug delivery systems and diagnostics. The company has strengthened its capabilities through key activities, including the acquisition of fill-finish facilities in the US and the integration of platforms such as Oval Medical Technologies, thereby improving its drug delivery capabilities. SMC establishes strong connections with OEMs and pharmaceutical companies to create new products through their research and development efforts. The company establishes strong vertical integration by controlling all design, molding, assembly, packaging, and global supply chain functions, while pursuing limited horizontal expansion into autoinjectors and combination products, which helps it grow its presence in the North American medical device plastics market.

Phillips-Medisize (US) built its business model around a complete outsourcing service that delivers integrated design and development services to North American OEMs, along with its extensive manufacturing capabilities for sophisticated medical plastic products. The company possesses core technical skills that enable advanced injection molding and micro-molding operations, together with cleanroom assembly work and deep knowledge of drug delivery systems, diagnostic equipment, and connected health technologies. The company creates new products through its digital health solutions and its device development process, which focuses on patient needs. The company operates multiple facilities in North America and works with its parent company, Molex, to enhance its capabilities in electronics integration and connectivity products. Phillips-Medisize establishes partnerships with pharmaceutical and medtech companies to develop next-generation delivery systems. The company operates multiple business units that design products and handle tooling, molding, assembly, and supply chain management, while it expands into connected devices and combination products, which strengthen its position in the medical device plastics market.

Freudenberg Medical (US) operates on a business model centered on providing high-value contract manufacturing services and engineering solutions for medical device plastics requiring advanced manufacturing techniques to develop minimally invasive, catheter-based, and implantable medical devices for the North American markets. Its core competencies include advanced extrusion, precision injection molding, silicone and thermoplastic processing, and cleanroom assembly, which scientists developed through their material science knowledge and design creation skills.

The company develops new biocompatible polymers that deliver high performance to meet regulatory and clinical assessment standards. The organization maintains its main operations through facility expansion projects in the US and Costa Rica. The organization partners with top original equipment manufacturers to create unique medical products. The company operates as a division of Freudenberg Group, which enables it to utilize shared resources for research and development and material innovation activities. The company integrates all its design processes, material selection, and manufacturing and assembly operations, which it handles in its own facilities, while developing new product lines for advanced catheter systems and minimally invasive medical devices.

NORTH AMERICA MEDICAL DEVICE PLASTICS MARKET: COMPANY EVALUATION MATRIX

Phillips-Medisize (Star) maintains market leadership in the North America medical device plastics market through its complete range of design engineering and high-volume production services, which create complex medical device plastic components. The company uses its advanced injection molding and assembly technologies, backed by strong research and development capabilities, to create products that achieve precise tolerances while meeting regulatory standards. Its integrated drug delivery systems, diagnostic devices, and connected healthcare solution products have propelled the company to become a market leader.

The company maintains market leadership through its worldwide operations and partnerships with pharmaceutical and medtech firms, as well as its research into biocompatible plastics and high-performance plastic materials. Protolabs (Emerging Player) is gaining traction in the North American medical device plastics market through its rapid prototyping and on-demand manufacturing capabilities. The company uses advanced technologies, which include injection molding, CNC machining, and 3D printing, to produce plastic parts with fast production times and low-volume requirements. The company's digital manufacturing platform enables medical device startups and innovation-focused projects to develop products at an accelerated pace. Protolabs has emerged as a rapidly expanding market competitor due to its growing investments in healthcare solutions and its ability to manufacture high-quality, personalized plastic parts.

NORTH AMERICA MEDICAL DEVICE PLASTICS MARKET: MARKET RANKING

The ranking of companies is based on several key factors that reflect their market position, capabilities, and overall contribution to the industry. The top 5 players in the North America medical device plastics market have been identified based on their revenue, market share, product offerings, production capacity, innovation, technological advancements, geographical presence, strategic partnerships, financial performance, and sustainability efforts. These key players continue to lead the market by maintaining a competitive edge and delivering high-quality medical device plastics to various end-use industries. Major players operating in the market include SMC Limited (US), Phillips Medisize (US), Freudenberg Medical (US), Jabil (US), Spectrum Plastics Group (US), Proto Labs (US), and Technimark LLC (US).

Related Reports:

North America Medical Device Plastics Market by Plastic Type (Standard Plastics, Engineering Plastics), Source (Fossil-Based and Bio-Based), Manufacturing Process (Extrusion, Cnc Machining, Injection Molding, Vacuum Casting), Application (Manufacturing, Prototyping), And Region - Global Forecast To 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]